Concepedia

Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation

Gregg W. Stone, Alexandre Abizaid, Yoshinobu Onuma, Ashok Seth, John A. Ormiston, Takeshi Kimura, Bernard Chevalier, Ori Ben‐Yehuda, Ovidiu Dressler, Tom McAndrew,

Journal of the American College of Cardiology · 2017 · 151 citations · 24 references

DOI

Concepts

References

24

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

, , +13

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

Stephen G. Ellis, Dean J. Kereiakes, D. Christopher Metzger et al. · New England Journal of Medicine · 2015 · 621 citations · Full text

, , +16

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek et al. · The Lancet · 2014 · 560 citations · Full text

, , +17

Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis

Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek et al. · Journal of the American College of Cardiology · 2011 · 525 citations

, , +14

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI

Joanna J. Wykrzykowska, Robin P. Kraak, Sjoerd H. Hofma et al. · New England Journal of Medicine · 2017 · 435 citations · Full text

, , +16